Issued Patents 2020
Showing 1–6 of 6 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 10800849 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2020-10-13 |
| 10765711 | Replication competent attenuated vaccinia viruses with deletion of thymidine kinase with and without the expression of human FLT3L or GM-CSF for cancer immunotherapy | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-09-08 |
| 10736962 | Recombinant MVA or MVADELE3L expressing human FLT3L and use thereof as immuno-therapeutic agents against solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Weiyi Wang, Peihong Dai +1 more | 2020-08-11 |
| 10639366 | Use of inactivated nonreplicating modified vaccinia virus Ankara (MVA) as monoimmunotherapy or in combination with immune checkpoint blocking agents for solid tumors | Liang Deng, Stewart Shuman, Taha Merghoub, Peihong Dai, Weiyi Wang | 2020-05-05 |
| 10577426 | Anti-GITR antibodies and methods of use thereof | Ana M. GONZALEZ, Nicholas Stuart Wilson, Dennis John Underwood, Volker Seibert, Olivier Leger +6 more | 2020-03-03 |
| 10548930 | Use of MVA or MVAΔE3L as immunotherapeutic agents against solid tumors | Liang Deng, Taha Merghoub, Stewart Shuman, Peihong Dai, Weiyi Wang | 2020-02-04 |